a Netherlands Institute for Innovative Ocular Surgery , Rotterdam , The Netherlands.
b Melles Cornea Clinic Rotterdam , Rotterdam , The Netherlands.
Curr Eye Res. 2019 Mar;44(3):243-249. doi: 10.1080/02713683.2018.1536215. Epub 2018 Dec 7.
Purpose/Aim: Evaluating the suitability of bioengineered collagen sheets and human anterior lens capsules (HALCs) as carriers for cultivated porcine corneal endothelial cells (pCECs) and in vitro assessment of the cell-carrier sheets as tissue-engineered grafts for Descemet membrane endothelial keratoplasty (DMEK).
pCECs were isolated, cultured up to P2 and seeded onto LinkCell™ bioengineered matrices of 20 µm (LK20) or 100 µm (LK100) thickness, and on HALC. During expansion, pCEC viability and morphology were assessed by light microscopy. ZO-1 and Na/K-ATPase expression was investigated by immunohistochemistry. Biomechanical properties of pCEC-carrier constructs were evaluated by simulating DMEK surgery in vitro using an artificial anterior chamber (AC) and a human donor cornea without Descemet membrane (DM).
During in vitro expansion, cultured pCECs retained their proliferative capacity, as shown by the positive staining for proliferative marker Ki67, and a high cell viability rate (96 ± 5%). pCECs seeded on all carriers formed a monolayer of hexagonal, tightly packed cells that expressed ZO-1 and Na/K-ATPase. During in vitro surgery, pCEC-LK20 and pCEC-LK100 constructs were handled like Descemet stripping endothelial keratoplasty (DSEK) grafts, i.e. folded like a "taco" for insertion because of challenges related to rolling and sticking of the grafts in the injector. pCEC-HALC constructs behaved similar to the DMEK reference model during implantation and unfolding in the artificial AC, showing good adhesion to the bare stroma.
In vitro DMEK surgery showed HALC as the most suitable carrier for cultivated pCECs with good intraoperative graft handling. LK20 carrier showed good biocompatibility, but required a DSEK-adapted surgical protocol. Both carriers might be notional candidates for potential future clinical applications.
评估生物工程胶原片和人眼前房晶状体囊(HALC)作为培养的猪角膜内皮细胞(pCEC)载体的适用性,并体外评估细胞载体片作为用于 Descemet 膜内皮角膜移植术(DMEK)的组织工程移植物的效果。
分离并培养 pCEC 至 P2 代,然后将其接种到 20 µm(LK20)或 100 µm(LK100)厚度的 LinkCell™生物工程基质和 HALC 上。在扩展过程中,通过相差显微镜评估 pCEC 活力和形态。通过免疫组织化学法检测 ZO-1 和 Na/K-ATP 酶的表达。通过体外模拟 DMEK 手术,使用人工前房(AC)和没有 Descemet 膜(DM)的人供体角膜评估 pCEC-载体构建体的生物力学特性。
在体外扩展过程中,培养的 pCEC 保留了其增殖能力,增殖标志物 Ki67 的阳性染色表明了这一点,细胞活力率也很高(96±5%)。在所有载体上接种的 pCEC 均形成了一层紧密堆积的六边形细胞,表达 ZO-1 和 Na/K-ATP 酶。在体外手术中,pCEC-LK20 和 pCEC-LK100 构建体的处理方式类似于 Descemet 剥离内皮角膜移植术(DSEK)移植物,即由于移植物在注射器中滚动和粘滞的相关挑战,它们像“玉米饼”一样折叠以便插入。pCEC-HALC 构建体在人工 AC 中的植入和展开过程中表现出类似于 DMEK 参考模型的行为,显示出与裸露基质的良好附着力。
体外 DMEK 手术显示 HALC 是培养的 pCEC 的最适合载体,具有良好的术中移植物处理效果。LK20 载体具有良好的生物相容性,但需要适应 DSEK 的手术方案。这两种载体都可能是潜在的未来临床应用的候选者。